NFE2L2 and neurodegenerative disease: Whether analogous impairments exist for other neurodegenerative diseases is yet to be established, although transcriptomic changes in Nrf2−/− mice closely mirror those in human Alzheimer’s disease [15], suggesting that Nrf2 signalling is also impaired in Alzheimer’s disease.